Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling.

Pulmonary fibrosis is a progressive disorder whose molecular pathology is poorly understood. Here we developed an in-house cDNA microarray ("lung chip") originating from a lung-normalized cDNA library. By using this lung chip, we analyzed global gene expression in a murine model of bleomycin-induced fibrosis and selected 82 genes that differed by more than twofold intensity in at least one pairwise comparison with controls. Cluster analysis of these selected genes showed that the expression of genes associated with inflammation reached maximum levels at 5 days after bleomycin administration, while genes involved in the development of fibrosis increased gradually up to 14 days after bleomycin treatment. These changes in gene expression signature were well correlated with observed histopathological changes. The results show that microarray analysis of animal disease models is a powerful approach to understanding the gene expression programs that underlie these disorders.

[1]  Kazuhisa Takahashi,et al.  Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. , 2001, American journal of respiratory cell and molecular biology.

[2]  S. Galli,et al.  Impaired mast cell-dependent natural immunity in complement C3-deficient mice , 1997, Nature.

[3]  David G. Morris,et al.  Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. J. Harris,et al.  The Annexin Protein Lipocortin 1 Regulates the MAPK/ERK Pathway* , 1999, The Journal of Biological Chemistry.

[5]  K Albrandt,et al.  An IgE-binding protein with a distinctive repetitive sequence and homology with an IgG receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Colebatch,et al.  Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume. , 1989, Thorax.

[7]  M. Soares,et al.  Normalization and subtraction: two approaches to facilitate gene discovery. , 1996, Genome research.

[8]  P. Opolon,et al.  Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. , 1997, The Journal of clinical investigation.

[9]  G. Tsujimoto,et al.  Functional genomic search of G-protein-coupled receptors using microarrays with normalized cDNA library. , 2002, Methods in enzymology.

[10]  J. Rosenbloom,et al.  Cytokine networks in the regulation of inflammation and fibrosis in the lung. , 1990, Chest.

[11]  B. Aronow,et al.  Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. , 2000, The Journal of clinical investigation.